BioMarin Pharmaceutical Inc. (BM8.DE)
€62.68 0.8%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
8 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on BioMarin Pharmaceutical Inc., AI stock picks, stock alerts and much more.
BM8.DE AI Stock Analysis
AI stock analysis for BM8.DE is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like BioMarin Pharmaceutical Inc. (BM8.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BM8.DE Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of BioMarin Pharmaceutical Inc. (BM8.DE), currently trading at €62.68, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BM8.DE
-
BioMarin Pharmaceutical Inc.
-
Symbol
BM8.DE
-
Market
XETRA
-
Industry
Biotechnology
-
Market Cap
11.9B
Similar Stocks
 |
Exelixis EX9.DE |
€34.82 0.1% |
5 |
 |
CureVac 5CV.F |
€2.74 0.7% |
4 |
 |
BioNTech SE 22UA.F |
€112.4 0.1% |
4 |
 |
Novavax NVV1.F |
€8.31 0.7% |
2 |
 |
MorphoSys AG MOR.DE |
€67.25 0.7% |
4 |
News
BM8.DE Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
Instagram Followers
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
App Downloads
Sign up to access
LinkedIn Employees
Sign up to access
Job Postings
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
BM8.DE Financials
BM8.DE Key Metrics
-
Total Revenue
$648.8M
-
Net Income
$88.7M
-
Earnings per Share
$0.47
-
Free cash flow
$12.9M
-
EBITDA
$126.4M
-
EBITDA Ratio
0.194879
-
Total Assets
$6.9B
BM8.DE 2-year Revenue & Income
BM8.DE 2-year Free Cash Flow
BM8.DE Technicals
BM8.DE SMA
BM8.DE RSI
FAQ
What's the current price of BioMarin Pharmaceutical Inc. (BM8.DE) Stock?
The price of an BioMarin Pharmaceutical Inc. (BM8.DE) share is €62.68.
What's the market cap of BioMarin Pharmaceutical Inc.?
The current market cap of BioMarin Pharmaceutical Inc. is 11.9B.
Should I buy or sell BM8.DE?
BioMarin Pharmaceutical Inc. shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, BioMarin Pharmaceutical Inc. is better viewed as a hold or accumulate position while waiting for further developments.
Is BioMarin Pharmaceutical Inc. a good investment?
The current analysis of BioMarin Pharmaceutical Inc.'s fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in BioMarin Pharmaceutical Inc.'s portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy BioMarin Pharmaceutical Inc. (BM8.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for BioMarin Pharmaceutical Inc. stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to BioMarin Pharmaceutical Inc. (BM8.DE) that investors often compare it to?
BioMarin Pharmaceutical Inc. (BM8.DE) is often compared to similar stocks such as Exelixis, CureVac, BioNTech SE, Novavax and MorphoSys AG.
What is the forecast for BioMarin Pharmaceutical Inc.'s stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast BioMarin Pharmaceutical Inc.'s stock price to be around €61.79 in 2025. Starting from the current price of €62.68, this represents a 1.4% change in price, indicating a neutral outlook for the stock.
How to buy BioMarin Pharmaceutical Inc. (BM8.DE) Stock?
BioMarin Pharmaceutical Inc. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy BioMarin Pharmaceutical Inc. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.